WHWK — Whitehawk Therapeutics Share News
0.000.00%
Last trade - 00:00- $183.00m
- -$6.98m
- $7.15m
Whitehawk Therapeutics Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Whitehawk Therapeutics Files Prospectus To Offer & Resale, From Time To Time, Of Up To 41.7 Million Shares By Selling Stockholder
Brief: Whitehawk Therapeutics Completes Strategic Transformation With Successful Closing Of Sale Of Aadi Subsidiary To Kaken Pharmaceuticals
Brief: Aadi Bioscience Inc changes name to Whitehawk Therapeutics
Aadi Bioscience Inc expected to post a loss of 22 cents a share - Earnings Preview
Aadi Bioscience Inc expected to post a loss of 22 cents a share - Earnings Preview
Brief: Aadi Bioscience Announces Closing of $100 Million PIPE Financing
Brief: Aadi Bioscience Announces Approval Of All Proposals At Special Meeting Of Stockholders
U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity
U.S. STOCKS ON THE MOVE-Spire, Copper miners, Abercrombie & Fitch
U.S. STOCKS ON THE MOVE-Mission Produce, Sirius XM, Carnival Corp
U.S. STOCKS ON THE MOVE-Humacyte, Ionis Pharmaceuticals, Emeren Group
U.S. STOCKS ON THE MOVE-FedEx, Eli Lilly, Aadi Bioscience
Aadi Bioscience gains on licensing agreement for cancer drugs
To Acquire Aadi Subsidiary Inc For $100 Million
Aadi Bioscience Inc expected to post a loss of 46 cents a share - Earnings Preview
Brief: Aadi Bioscience Says Loretta Itri Notified Board That Her Employment As Chief Medical Officer Will Cease Effective Oct. 1, 2024
U.S. RESEARCH ROUNDUP-Aadi Bioscience, Target, Visteon
U.S. STOCKS ON THE MOVE-Peabody Energy, Snowflake, Toll Brothers